ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing and commercialization of unique proprietary extracellular matrix (ECM) products to facilitate the repair and remodeling of damaged tissues. All ACell products are based on our proprietary Urinary Bladder Matrix (UBM) technology platform.

ACell is committed to becoming and remaining an innovative leader in regenerative medical technology. ACell, which was established in 2002, is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN.

ACell Vet is a subsidiary of ACell, Inc., and offers a complete line of regenerative medicine products for use in the veterinary field.